MLMengistu Legesse

Mengistu Legesse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mengistu Legesse has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the Spectrum of Clinical and Radiological Findings in Active Tuberculosis

    by Jelkeba Bali Weyesa, Mengistu Legesse, Balako Gumi, Wondwossen Amogne, Nega Berhe, Eyob Tekalign

    Background: Clinical data may not accurately diagnose pulmonary tuberculosis (PTB), mainly due to manifestation overlap with other diseases, causing delays and misdiagnoses. Many gaps in the interpretation of clinical and radiographic findings were addressed and updated in our study. Methods: An institutional-based study was carried out between 02/01/2018 and 26/06/2020 to clinically assess TB outpatients in high-burden zones. Those patients were identified through smear microscopy, GeneXpert Ultra, and chest X-rays and TB positives were interviewed. Of total, 329 patients were enrolled from Bench-Skeko, 23 from Skeka, and 29 from Keffa. Both descriptive and inferential statistics were performed using Stata 14/16. Results: A total of 410 TB confirmed cases, with 328 (80%) being PTB, 79 (19.3%) EPTB, and 3 (0.73%) involving both forms were involved in this study. The mean age was 27.65 ± 11.44 years, with 55% male. Most patients were recently identified (99.3%). GeneXpert was used in 62.4%, AFB in 8.78%, and lesion biopsy or FNAC for EPTB in 16.83%, and 98% was on the intensive therapy for susceptible TB. A febrile episode was diagnosed in 93% (5.4% >40°C, 87% < 39°C), night sweat in 93.17%, appetite loss in 89%, fatigue in 90%, and weight loss in 88%. Respiratory symptoms were very common, with cough reported in 94.2%: productive in 91%, and prolonged (>3 wks) in 77%. Abnormalities in chest X ray were reported in 16.3%, with pleural effusion in 11.2%, cavitary formations in 13%, and lymph node enlarged in 14%. Blood pressure abnormalities were relatively low, with 76.3% having normal. Only few findings were reported as statistically significant predictors of active PTB. Chest abnormalities (OR=6.87), prolonged cough (OR=6.4), mucoid (OR=14.6), and mucopurulent sputum (OR=56.4) increased PTB odds, while lymphadenopathy was less commonly reported (OR=0.16). Appetite loss (OR=3.26), pleural effusion (OR=2.41), and fibrosis (OR=2.31) showed weak associations. Conclusions: A high prevalence of the TB tetrad: prolonged cough, night sweat, fever and appetite loss were observed. PTB odds were higher with chest abnormalities, effusion, fibrosis, infiltration, and expansion, highlighting the diagnostic value of radiology.

  • Open Access

    Dried blood spots perform well in the quantification of HBV DNA and detection of HBeAg

    by Asegedech Asmamaw, Nega Berhe, Mengistu Legesse, Asgeir Johannessen

    Background: Hepatitis B virus (HBV) DNA quantification and hepatitis B e-antigen (HBeAg) detection are recommended in the management of chronic HBV infection. The use of dried blood spots (DBS) collected with fingerstick could improve access to these tests in resource-limited settings, but needs validation in a field setting. Methods: DBS samples were collected using fingerstick capillary blood from 143 HBV-infected individuals at Sebeta Health Centre, Ethiopia, covering the total range of quantification from < 2 to > 8 log 10 IU/ml. Plasma samples were collected in parallel using standard venipuncture whole blood. The Xpert ® HBV viral load assay was used to quantify HBV DNA. HBeAg detection was performed using the Alinity i HBeAg assay. DBS and plasma viral loads were compared using linear regression analysis. Stability studies were performed in 10 DBS samples stored at ambient temperature for up to 24 weeks. Results: HBV DNA was detected in all 89 DBS samples with plasma HBV DNA above the WHO-recommended decision threshold of 3.3 log 10 (= 2000) IU/ml. A strong correlation (R 2 = 0.90) was observed between plasma and DBS, with a mean difference of 0.23 log 10 IU/ml. DBS had 85.7% sensitivity and 92.9% specificity for the detection of HBeAg. No clinically relevant change of HBV DNA was observed in DBS stored at room temperature up to 12 weeks; however, a reduction of more than 0.5 log 10 IU/ml was observed in 4 of 10 DBS samples at week 24. Conclusions: DBS is a reliable sample matrix for HBV DNA quantification and HBeAg detection in resource-limited settings.

  • Open Access

    Diagnostic performance of RNA extraction-free dilution and heating method for the detection of severe acute respiratory syndrome coronavirus 2

    by Getnet Hailu, Molalegne Bitew, Girmay Medhin, Adamu Tayachew, Nebiyou Yemanebirhan, Andargachew Gashu, Samuel Ayele, Admikew Agune, Assefa Konda, Mengistu Legesse

    Real-time quantitative polymerase chain reaction remains the gold standard for COVID-19 diagnosis, but RNA extraction is time-consuming, expensive, and associated with increased biosafety requirements. This study evaluated an extraction-free dilution and heating (EFDH) method as a simplified alternative to conventional extraction-based (EB) real-time quantitative polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 detection. A total of 300 archived nasopharyngeal specimens, including 190 positives and 110 negatives, from the National Virology Reference Laboratory at the Ethiopian Public Health Institute, were analyzed. Samples were diluted 1:2 with RNase-free water, heated at 72°C for 15 min, and analyzed using an ABI 7500 Fast instrument. The EFDH method showed a sensitivity of 92%, a specificity of 100%, and an overall accuracy of 85.8%, producing 15 false-negative and 12 invalid results. Agreement with the EB method was high, with 95% concordance and a kappa coefficient of 0.89. Performance was strongest in samples with high viral loads (cycle threshold [Ct] < 20) and declined in those with low viral loads (Ct > 35). A significant correlation was observed between the two methods (R2 = 0.99, p=0.001). These findings indicate that the EFDH approach reliably detects moderate-to-high viral loads and may serve as a practical testing option in resource-limited settings, especially during outbreaks when rapid and simplified workflows are needed.

  • Open Access

    SARS-CoV-2 Genetic Variants Identified in Selected Regions of Ethiopia Through Whole Genome Sequencing: Insights from the Fifth Wave of COVID-19

    by Getnet Hailu, Mengistu Legesse, Andargachew Mulu, Girmay Medhin, Mesfin Mengesha Tsegaye, Dawit Hailu Alemayehu, Abaysew Ayele, Atsbeha Gebreegziabxier, Adamu Tayachew, Adimkewu Aguine, et al.

    Background: The COVID-19 pandemic highlighted SARS-CoV-2 variants with increased transmissibility and immune evasion. In Ethiopia, where cases surged, the understanding of the virus’s dynamics was limited. This study analyzed SARS-CoV-2 variants during the fifth wave, crucial for guiding vaccines, therapeutics, diagnostics, and understanding disease severity. Method: From June to August 2022, 150 SARS-CoV-2-positive samples were randomly selected from the Ethiopian Public Health Institute repository. Sixty-three high-quality genome sequences were analyzed. Results: Of the 63 sequences, 70% were from males and 30% from females, with a median age of 34. Omicron dominated (97%, 61/63), primarily clade 22A (64%, 40/63), followed by 22B (18%, 11/63) and 21K (14%, 9/63). Delta accounted for 3.2% (2/63). Omicron was identified in all (25) vaccinated study participants. Ethiopian sequences showed limited evolutionary divergence and lower genetic diversity compared to global sequences. Conclusion: Omicron was the predominant variant during Ethiopia’s fifth wave, indicating recent community transmission. Despite minor genetic diversity differences, ongoing surveillance remains critical for tracking variants and informing public health interventions.


  • Open Access

    Seroprevalence of West Nile Fever and Associated Risk Factors in Livestock of Afar Region, Northeast Ethiopia

    by Jemberu Alemu Megenas, Mengistu Legesse Dadi, Tesfu Kassa Mekonnen, James W. Larrick, Gezahegne Mamo Kassa

    Sub-Saharan Africa has long been prone to widespread mosquito-borne diseases affecting both humans and animals. However, the presence and impact of West Nile virus (WNV) among livestock in Ethiopia have not been thoroughly investigated. The objective of this study was to investigate the seroprevalence of West Nile virus in livestock in the Afar region using serological methods. A total of 736 serum samples were collected from 224 cattle, 155 camels, 144 sheep, 121 goats, and 92 donkeys in the Amibara and Haruka districts of the Afar region selected using haphazard sampling. Among 736 tested livestock serum samples, 50.7% (373/736) showed anti-WNV IgG antibodies evaluated using the ID screen® WNV competition multispecies ELISA kits (95% CI: 47–54.4%; p < 0.01). The seroprevalence was higher (p < 0.01) in donkeys (76.1%), followed by camels (69.1%), cattle (52.2%), goats (34.7%), and sheep (25.7%). The study showed a statistically significant difference of WNV seropositivity between species of animals AOR (1.5), 95% CI (1.038–2.212) (p < 0.01). Compared with sheep, donkeys had a seven-fold higher chance of being seropositive for WNV infection (OR: 6.447, 95% CI = 3.888–10.688) (p < 0.01). This study emphasizes how common WNV infection is in Ethiopia’s pastoral Afar region. It is imperative to consider consistent surveillance of WNV infection and prompt management of identified WNV disease in clinical practice. A clear need exists to build additional research capacity regarding WNV infections among both humans and animals.


  • Open Access

    Diagnostic Performance of RNA-Extraction-Free Diagnostic Method for Detecting SARS-CoV-2 Through Dilution and Heating Steps

    by Getnet Hailu Alemayehu, Molalegne Bitew, Girmay Medhin, Adamu Tayachew Mekonnen, Nebiyou Y. Woldeamanuele, Andargachew Gashu Mengistie, Samuel Ayele, Admikew Agunie Asfaw, Asefa Konde Korkiso, Mengestu Legesse

    Background: RT-qPCR is the gold standard for diagnosing COVID-19, the testing process requires RNA extraction, which can be time-consuming, costly and infectious. This study aimed to compare the diagnostic performance of an extraction-free heating and dilution method (EFHD) with conventional extraction-based (EB) methods for detecting SARS-CoV-2. Method: A total of 300 specimens, (190 positive, 110 negative) were collected retrospectively from the National Virology Reference Laboratory repository of Ethiopian Public Health Institute (EPHI). The specimens were diluted in 1:2 with RNase-free water and heated at 72°C for 15 minutes. 10µL of the heated sample/ elutes were mixed with 20µL of the master mix and runned using an ABI 7500 Fast instrument (ThermoFisher Scientific). Performance characteristics were analyzed using R-Studio and STATA v17. Result: The EFHD revealed a sensitivity of 92% and a specificity of 100%. The accuracy of the new method was 85.8% (163/190). The new method reported 15 false negatives and 12 invalid results. The EFHD method exhibited strong agreement with the standard method, (with an agreement of 95%, and a kappa coefficient of 0.89). It performed well with high viral load samples (Ct < 20), but exhibited reduced sensitivity for lower viral loads (Ct > 35). The study confirmed a significant correlation (R² = 0.99, p = 0.001) between EFHD and extraction-based SARS CoV-2 detection methods. Conclusion: EFHD demonstrated good performance characteristics. Its tendency to produce false negatives in low viral load cases suggests room for improvement. This method could be the choice of testing in resource-limited areas specially for outbreak management and control.

  • Open Access

    Training and Active Case Detection to Prevent Leprosy: Effect on Knowledge, Attitude and Skills of Health Workers on Early Diagnosis of Leprosy in a Leprosy Hotspot District in Ethiopia

    by Ephrem Mamo, Dareskedar Tsehay, Seid Hassen, Solomon Getahun, Addis Mengiste, Beletshachew Tadesse, Tesfaye Tadesse, Mengestu Legesse, Kidist Bobosha

    Background: Despite all of the efforts, leprosy continues to affect hundreds of thousands of people every year, including children, showing the ongoing transmission of the disease within the population. The transmission of leprosy can be interrupted through an integrated approach that includes active case-finding, contact tracing and capacity building of health workers. Methods: A cross-sectional study design was used to assess the knowledge, attitudes and skills of health workers in the screening and diagnosis of leprosy. One hundred and eighty-one and eighty-eight health care workers participated in the pre-and post-assessment surveys, respectively. Data were collected through interviews and an observational checklist. Frequency tables and graphs were used to describe the study variables, and statistical significance between pre- and post-assessment surveys was declared at p-value < 0.5. Result: The percentages of healthcare workers with good knowledge, positive attitudes and skills were 61.2%, 55.6% and 51.7% in the pre-assessment survey and 77.3%, 56.3% and 75.0%, respectively, in the post-assessment survey. There was a significant improvement in the knowledge and skill scores of participants in the post-assessment survey (p < 0.01). During the campaign, 3780 index contacts were screened; 570 (15.1%) were diagnosed with skin diseases, and 17 new leprosy cases were diagnosed (case detection rate of 45 per 10,000 contacts). Conclusion: Training improved the knowledge and skills of healthcare workers, and a large number of skin diseases were detected through mass screening and active case findings. Providing training for frontline healthcare workers contributed to the detection of more cases and facilitated early detection of leprosy cases.


  • Open Access

    Seroprevalence and Co‐Circulation of Rift Valley Fever Virus and West Nile Fever Virus in Livestock Population of Afar Region, Northeast Ethiopia

    by Jemberu Alemu Megenas, Mengistu Legesse Dadi, Tesfu Kassa Mekonnen, James W. Larrick, Gezahegne Mamo Kassa

    The distribution, epidemiology, and socioeconomic impact of Rift Valley fever (RVF) and West Nile (WN) viruses are poorly known in areas of sub‐Saharan countries like Ethiopian pastoral region. The human and livestock density in the area has increased greatly in recent years, but little work has been done on arboviral diseases and their potential impact on human and livestock health. The aim of this study was to detect the circulation of zoonotic arboviruses such as Rift Valley fever virus and West Nile viruses in the livestock population and to estimate seroprevalence in Afar pastoral area northeast Ethiopia. Cross‐sectional serological survey was carried out in 736 serum samples from which cattle (224), camel (155), goats (121), sheep (144), and donkeys (92) were tested for the presence of anti‐RVFV and anti‐WNV IgG using a competitive enzyme‐linked immunosorbent assay (c‐ELISA) in two purposively selected districts of the Afar region. The present study revealed a 9.1% (95% CI = 8.86–9.29) seroprevalence of co‐circulation of RVF and WNV. High 32/155 (20.7%) seroprevalence of co‐circulation was seen in camels, followed by goat 14/121 (11.6%), cattle 16/224 (7.14%), and sheep 5/144 (3.5%), respectively, and higher 41/421 (9.7%) seroprevalence of co‐circulation was observed in Amibara district than Haruka district. Camels were seven times (OR: 7.016, 95% CI = 2.639–18.653) more likely to be seropositive for the co‐circulation than sheep (p ≤ 0.001). Livestock herds found in Amibara district were 1.2 times (OR: 1.165, 95% CI = 0.680–1.996) more likely to be seropositive for RVFV infection than those in Haruka areas. Given the co‐occurrence of RVFV and WNV circulations, along with often suboptimal human and animal health surveillance in many similar areas’ attention should be given. Investigation of the potential socioeconomic and health impacts of zoonotic arbovirus infections in such areas is crucial. Since both RVFV and WNFV are transmitted through a mosquito vector, avoiding mosquito bites is the primary method of prevention.


  • Open Access

    PA-151 PEP4LEP case detection delay reliability or measurement consistency testing in Mozambique, Ethiopia, and Tanzania – preliminary results

    by Ephrem Gebrehiwot, Thomas Hambridge, Anne Schoenmakers, Kidist Bobosha, Mengistu Legesse, Christa van Wijk, Janhendrick Richardus, Kitesa Debelo, Fufa Daba, Nelly Mwageni, et al.

    Background Detection delay is defined as the period between onset of first signs and symptoms of leprosy and the time of diagnosis, comprising of a ‘patient delay’ and a ‘health-system delay’ and reliability refers to the consistency of a measure. Three types of consistency are considered: over time (test-retest reliability), across items (internal consistency), and across different researchers (interrater reliability). For the case detection delay (CDD) two are applicable: test-retest reliability and interrater reliability. Methods The study was conducted in Ethiopia, Mozambique and Tanzania. The CDD questionnaire was administered to 79 leprosy patients. One month later, another researcher re-administered the CDD questionnaire with these same patients. Interrater reliability was assessed using the intra class correlation coefficient (ICC). The test-retest reliability was assessed among 69 leprosy patients by determining the CDD at one month difference, both times using the same rater, and then we determined the reliability by looking at the Pearson correlation between the two sets of CDD data. Results Results from 79 leprosy patients show that, 3 (3.8%) were children under 15 years of age and 25 (31.6%) were women. Interrater reliability: the first interviews led to a mean CDD of 24.0 months (95% CI =17.1 - 30.9). The second interviews, also led to a mean CDD of 24.0 months (95% CI =17.7 - 30.3). For the test-retest reliability, the mean CDD of the first and second interviews were 16.5 (95% CI =13.6 - 19.5) and 16.9 (95% CI =13.8 - 20.1) respectively: the interrater reliability measured with ICC was 0.89 (95% CI of 0.84 - 0.93). Test-retest repeatability coefficient was 0.90 (p = 0.01). Conclusion The PEP4LEP CDD tool to determine the case detection delay of newly diagnosed leprosy patients, was validated in the three African countries showing that both test-retest and interrater reliability measurements demonstrated good reliability of the instrument.